In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins
- 1 September 1980
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 18 (3) , 476-479
- https://doi.org/10.1128/aac.18.3.476
Abstract
Moxalactam, Ro 13-9904, cefotaxime, cefoperazone, older cephalosporins, and four aminoglycosides were tested in vitro against 432 strains of gram-negative bacteria isolated from pediatric patients. The new drugs were uniformly active against coliform bacilli obtained from patients with meningitis and against aminoglycoside-resistant coliform bacilli.This publication has 2 references indexed in Scilit:
- INTRAVENOUS CEFOTAXIME IN CHILDREN WITH BACTERIAL MENINGITISThe Lancet, 1980
- A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancyThe Journal of Pediatrics, 1976